Furthermore, several experiments—including scratch assays, tube formation assays, cell permeability assays, and cell viability assessments—were conducted to explore the effects of TCF12 and HIF-1α on vascularization and drug sensitivity in liver cancer. This evidence concerns the gene TCF12 and liver cancer.